In a previous study of our group, we showed that EZH2 mRNA levels are increased in subset #1 when compared with indolent subset #4, thus implicating for the first time EZH2 in the pathophysiology of aggressive CLL (43). Here, EZH2 is linked to B-cell chronic lymphocytic leukemia.